Faculty and Staff
The Center for Addiction Medicine maintains a highly collaborative team with backgrounds in behavioral interventions, neuroimaging, and cognitive neuroscience. Faculty, post-docs, and staff all provide the complementary skills and expertise needed to study the underlying causes and risk factors of addictive behavior and to test new treatments for addictive disorders. The faculty and fellows have appointments at both Harvard Medical School and Massachusetts General Hospital.
Founding Director and Principal Investigator, Center for Addiction Medicine; Cox Family Professor of Psychiatry in the Field of Addiction Medicine, Harvard Medical School
Dr. Evins is the Cox Family Professor of Psychiatry in the field of addiction medicine at Harvard Medical School and the founder and director of the Center for Addiction Medicine at MGH. Dr. Evins completed her residency in adult psychiatry at the Massachusetts Mental Health Center and the Longwood Psychiatry Residency Training Program. In addition, she completed…more
Associate Director, Center for Addiction Medicine; Program Director, Addiction Recovery Management Service; Founder and Director, Recovery Research Institute; Professor of Psychiatry, Harvard Medical School
Dr. Kelly is the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine at Harvard Medical School, the founder and Director of the Recovery Research Institute at MGH. The American Psychological Association (APA) Society of Addiction Psychology, and is also a Fellow of APA. He has served as a consultant to U.S. federal agencies…more
Program Director, Center for Addiction Medicine; Assistant in Research Psychiatry and Instructor of Psychiatry, Harvard Medical School
Dr. Pachas received her medical degree from San Martin de Porres University and received health services management and public health training from the National University Mayor de San Marcos in Lima, Peru. She also completed an Addiction Fellowship at Harvard Medical School. Her research interests are the development of behavioral treatments and evidence-based novel treatments for smoking cessation and relapse prevention in people with…more
Director of Psychological Services, MGH Schizophrenia Program; Psychologist, Massachusetts General Hospital; Associate Professor of Psychology, Harvard Medical School
Dr. Corinne Cather earned her undergraduate degree in biopsychology at Hamilton College in Clinton, NY and her doctorate in clinical psychology from Rutgers University where she received specialized training in cognitive behavioral therapy (CBT) and behavioral medicine. She completed an internship at the University of Medicine and Dentistry of New Jersey (formerly Rutgers) and joined…more
Director of Neuroscience and Principal Investigator, Center for Addiction Medicine; Associate Professor, Harvard Medical School
Dr. Gilman received her BS from Tufts University in 2004, and her Ph.D. in Neuroscience from Brown University in 2008, where she used neuroimaging techniques to study the acute and long-term functional and structural effects of alcohol on brain regions involved in motivation and emotion. She came to CAM in January 2013 to study the…more
Director of Neuropsychology and Principal Investigator, Center for Addiction Medicine; Assistant Professor, Harvard Medical School
Dr. Schuster is a licensed clinical psychologist. She received her BA from the University of Maryland, College Park and her Ph.D. in Clinical Psychology from the University of Illinois at Chicago in 2014. In graduate school, she was funded by a NIDA National Research Service Award to study the cognitive effects of cannabis and tobacco use among…more
Director of Biostatistics and Principal Investigator, Center for Addiction Medicine; Assistant Professor, Harvard Medical School
Dr. Hoeppner is a health psychologist with expertise in fine-grained longitudinal methodology, which she uses to explicate the mechanisms underlying behavioral change. During her graduate training (Univ. of RI, MA in psychology in 2003, M.S. in statistics in 2005, Ph.D. in psychology in 2007), Dr. Hoeppner collaborated on numerous health behavior change projects, which used…more
Director of Dual Diagnoses Studies at the Depression Clinical Research Program; Principal Investigator; Assistant Professor of Psychology, Harvard Medical School
Dr. Pedrelli is a clinical psychologist with expertise in comorbid disorders. She received her Ph.D in Clinical Psychology from the Joint Doctoral Program at the University of California San Diego and San Diego State University and completed her post-doctoral work at MGH. Her program of research focuses on explicating the etiology of co-occurring Mood Disorders and…more
Associate Director, Research Recovery Institute; Instructor, Harvard Medical School
Dr. Bergman is a research scientist in the Recovery Research Institute (RRI) within CAM, and a licensed staff psychologist in the hospital’s Addiction Recovery Management Service (ARMS), where he treats adolescents and young adults with substance use disorders (SUD). He also serves nationally as the secretary for Division 50 of the American Psychological Association (Addiction…more
Co-Investigator and Study Physician
Dr. Kristina Schnitzer graduated from NYU School of Medicine in 2015 and the MGH/McLean Adult Psychiatry Residency Program in 2019. She completed a one-year fellowship in Public and Community Psychiatry through MGH and the Department of Mental Health prior to beginning her K12, ,…more
Dr. Vilsaint is a community psychologist. She is a research fellow at Harvard Medical School and a Principal Investigator at the Recovery Research Institute and Center for Addiction Medicine at Massachusetts General Hospital. Her research has focused on racial health equality and recovery from addiction…more
Dr. David Eddie is a research scientist at Massachusetts General Hospital’s Center for Addiction Medicine and Recovery Research Institute, a clinical psychologist in Massachusetts General Hospital’s Department of Psychiatry, and an assistant professor at Harvard Medical School. His current NIAAA-supported research is seeking to better understand affective and psychophysiological factors that heighten addiction relapse… more
Clinical and Research Fellow
Dr. Kate Bentley received her Ph.D. in Clinical Psychology in 2017 from Boston University and completed her pre-doctoral internship in the Cognitive Behavioral Therapy track at Massachusetts General Hospital/Harvard Medical School. Her research is largely focused on the development, evaluation, and implementation of transdiagnostic interventions for suicidal and non-suicidal self-injurious thoughts and behaviors. Her postdoctoral…more
Dr. Kevin Potter graduated from Grinnell College with a B.A. in Psychology and received his Ph.D. in Quantitative Psychology from Ohio State University. He began working for the Center for Addiction Medicine in August of 2018 as a statistician. His research involves applying modern statistical…more
Dr. Megan Cooke is broadly interested in how an individual’s genes, brain, and environment come together to shape their trajectory from substance initiation to substance dependence. She graduated with a BS in Psychology from Furman University in 2008. She received her PhD in Clinical and Translational Science with a concentration in…more
Dr. Brenden Tervo-Clemmens is a post-doctoral fellow at Massachusetts General Hospital/Harvard Medical School in the MGH/NIDA K12 Career Development Program in Substance Use and Addiction Medicine. Brenden received his Ph.D. in Clinical Psychology in 2021 from the University of Pittsburgh, with secondary training in…more
Addiction Psychiatry Fellow
Dr. Jawad Husain is an early career psychiatrist investigator with interests in addiction psychiatry and research on cannabidiol as a novel psychopharmacological therapy. He graduated medical school and psychiatry residency at Boston University and enrolled at BU School of Public Health for an MPH. Currently, he is a Mass General Brigham Addiction Psychiatry Fellow, in…more
Research Nurse, Co-Investigator
Sarah Hickey received her B.S. in Neuroscience at Stonehill College and received her B.S. in Nursing from Northeastern University. She began working at CAM in March of 2019, where she is currently a co-investigator on Dr. Gilman’s study which uses functional near-infrared spectroscopy to assess the …more
Project Manager, iDECIDE
Caroline Gray received a Bachelor of Science in Psychology from Virginia Tech and her M.S.W. from the University of South Carolina. Caroline joined CAM in July 2021 and works primarily on the iDECIDE project, under Dr. Randi Schuster. Prior to her time at CAM, she was at the American Academy of Addiction Psychiatry, where she was a project manager…more
Clinical Research Coordinator
Julia Jashinski graduated from Ohio State University in 2019 with a B.S. in public health and received her M.S.W. from Boston University in 2021. At CAM, she primarily works with Dr. Gilman on the prescription opioid tapering study, which looks at the effect of medical marijuana and behavioral interventions on pain and opioid dose. She also works on Dr. Gilman’s medical marijuana study, which looks at the effects of medical marijuana on neurocognition and escalation of use. Her research interests include harm reduction, substance use treatment, and health equity.
Clinical Research Coordinator II
Chelsea Pike graduated from Dartmouth College in 2021 with a Bachelor of Arts in psychology and a minor in English/creative writing. At CAM, she primarily works with Dr. Gilman on the CBD study, which uses PET/MRI imaging to investigate whether CBD, compared to placebo, reduces pain- and depression-related neuroinflammation in patients with chronic low back pain. Her research interests include prenatal substance use, and episodic future thinking as a treatment for substance use.
Clinical Research Coordinator II
Sarah Knoll graduated from the University of Maryland, College Park with a Bachelor of Arts in psychology. At CAM, she works primarily with Dr. Schuster on two studies, one examining the effects of cannabis abstinence on cognition and the other examining the effect of acute cannabis abstinence on suicidal ideation and depressive symptoms in adolescents. Her research interests include accessibility, scalability, and effectiveness of mental health interventions and treatments for underserved youth populations.
Clinical Research Coordinator II
Emily Edgington graduated from the University of South Florida with a bachelor’s degree in psychology and from James Madison University with a Master’s degree in Behavior Analysis. At CAM, she works primarily with Dr. Schuster on studying the effectiveness of a drug education and diversion program for middle and high school students. Her research interests include impulsivity and temporal discounting as they relate to substance use behaviors.
Clinical Research Coordinator
Vanessa Iroegbulem graduated from Augustana College with a Bachelor of Arts in neuroscience and women, gender, and sexuality studies with a minor in philosophy. At CAM, she works primarily with Dr. Schuster and Dr. Evins on the vaping cessation in adolescents study, which seeks to evaluate the efficacy of varenicline, added to texting and group behavioral support, for the cessation of vaped nicotine in adolescents. Her research interests include harm reduction, health equity, and accessibility and effectiveness of substance use treatment in marginalized and underserved populations.
Programmer/Clinical Research Coordinator II
Lindsay Nielsen graduated from the University of St. Andrews in 2021 with a BSc (Hons) degree in neuroscience. At CAM, she works with Dr. Eden Evins and Dr. Schnitzer on the Patient-Centered Outcomes Research Institute (PCORI) funded study that investigates smoking cessation treatments for smokers with serious mental illnesses. She is also working on a study with Dr. Schuster and Dr. Evins that examines the efficacy of varenicline and behavioral support for vaping cessation in adolescents. Her interests include researching and implementing treatments for substance use disorders, as well as providing support for mental comorbidities.
Michael Pascale graduated from the University of Massachusetts Lowell in 2020 with a Bachelor of Science in computer science and minors in psychology and mathematics. His previous work has involved software development and project management in several cognitive labs. His present work is with data from a study which used fNIRS to assess THC impairment and the effects of THC intoxication on the frontal lobe. Additionally, he acts as data manager for the Center. Michael’s interests are attention, learning, education, and science communication and he plans to deepen his understanding of these topics through a graduate program in cognitive psychology.